False-Positive Galactomannan Test Results in Multiple Myeloma.

ABSTRACT:

Background/objectives

Invasive pulmonary aspergillosis (IA) is a common infectious disease in patients with hematological diseases. The prevention, early detection, and establishment of treatment strategies for IA are important. The serum galactomannan antigen (GM) mycological test for IA diagnosis, included in the mycology criteria of the European Organization for Research and Treatment of Cancer-Invasive Fungal Infections Cooperative Group/National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC/MSG), is widely used because of its high sensitivity and specificity. However, false-positive results are a concern.

Methods

We retrospectively analyzed all GM tests performed at our department in the clinical practice setting between April 2003 and January

SUBMITTER: Nakamura S 

PROVIDER: S-EPMC12026058 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature